Hohimer Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,426
Closed -$269K 345
2025
Q3
$269K Buy
+2,426
New +$276K 0.04% 231
2024
Q4
Sell
-45,358
Closed -$3.8M 250
2024
Q3
$3.8M Buy
45,358
+47
+0.1% +$3.59K 0.82% 45
2024
Q2
$3.11M Sell
45,311
-6,067
-12% -$405K 0.72% 55
2024
Q1
$3.76M Sell
51,378
-400
-0.8% -$30.8K 0.88% 34
2023
Q4
$4.19M Buy
51,778
+482
+0.9% +$37.5K 1.06% 24
2023
Q3
$3.84M Sell
51,296
-1,289
-2% -$99.1K 1.1% 25
2023
Q2
$4.05M Sell
52,585
-1,900
-3% -$152K 1.12% 18
2023
Q1
$4.52M Sell
54,485
-1,475
-3% -$122K 1.31% 13
2022
Q4
$4.8M Sell
55,960
-514
-0.9% -$40.7K 1.53% 13
2022
Q3
$3.48M Buy
56,474
+796
+1% +$50.2K 1.12% 24
2022
Q2
$3.44M Sell
55,678
-2,819
-5% -$175K 1.02% 29
2022
Q1
$3.48M Buy
58,497
+3,939
+7% +$252K 0.69% 52
2021
Q4
$3.96M Sell
54,558
-6,181
-10% -$426K 0.83% 36
2021
Q3
$4.24M Buy
60,739
+581
+1% +$40.8K 0.89% 35
2021
Q2
$4.14M Buy
60,158
+3,970
+7% +$265K 0.85% 39
2021
Q1
$3.63M Buy
56,188
+4,702
+9% +$303K 0.88% 35
2020
Q4
$3M Buy
51,486
+27,491
+115% +$1.66M 0.8% 35
2020
Q3
$1.45M Sell
23,995
-743
-3% -$51.5K 0.41% 83
2020
Q2
$1.9M Sell
24,738
-7,969
-24% -$611K 0.66% 48
2020
Q1
$2.61M Buy
32,707
+4,103
+14% +$284K 1.1% 22
2019
Q4
$1.86M Buy
+28,604
New +$1.86M 0.65% 56

Other funds holding GILD

Hohimer Wealth Management's GILD Position: Q4 2025 in Review

Hohimer Wealth Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,426 shares — an estimated $269K sold.

Hohimer Wealth Management first reported a position in GILD in Q4 2019 and held it in 21 quarters. The position peaked at $4.8M in Q4 2022. 2,227 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Hohimer Wealth Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Hohimer Wealth Management sold 2,426 Gilead Sciences shares in Q4 2025, an estimated $269K.
  • Hohimer Wealth Management first reported a position in Gilead Sciences in Q4 2019 and held it in 21 quarters.
  • Hohimer Wealth Management's Gilead Sciences position peaked at $4.8M in Q4 2022.
  • 2,227 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Hohimer Wealth Management's 13F filing for Q4 2025, filed 12 Feb 2026.